News
-
-
-
-
-
PRESS RELEASE
Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada
MedMira Inc. announces full clinical trials for Multiplo® Complete Syphilis (TP/nTP) Antibody Test in Canada with REACH Nexus at MAP Centre for Urban Health Solutions. The innovative test combines screening and confirmation in under 3 minutes -
-
-
-
-
PRESS RELEASE
Dominari Securities LLC Receives Milestone Approval as a Nasdaq Limited Underwriting Member
Dominari Holdings Inc. announces approval of Dominari Securities LLC as Limited Underwriting Member of Nasdaq Stock Market, enabling underwriting transactions for Nasdaq listings. CEO Kyle Wool sees it as a key milestone for business development